Transcranial magnetic stimulation (TMS) involves the use of a very short pulsed magnetic field to stimulate nerve cells in the brain. The Psychiatric Research Institute has joined the ranks of prestigious health centers around the country now offering transcranial magnetic stimulation therapy for patients with major depressive disorder.
Similar to a magnetic resonance imaging (MRI) scanner, transcranial magnetic stimulation therapy stimulates areas of the brain that are underactive in depression. Performed on an outpatient basis, transcranial magnetic stimulation is performed while the patient sits comfortably in a relaxing chair. Sessions take a little more than 30 minutes and are administered five days a week for up to four to six weeks.
With transcranial magnetic stimulation, there are none of the side effects commonly associated with antidepressant medication and patients remain awake and alert throughout the treatment. Transcranial magnetic stimulation is approved by the U.S. Food and Drug Administration for the treatment of depression, and has shown to be effective in helping those patients who have failed to benefit from medications. No sedation is necessary during the therapy and there is minimal discomfort throughout the treatment.
PRI is utilizing the NeuroStar TMS Therapy System, a state-of-the-art process that is available to those patients meeting the necessary criteria. Transcranial magnetic stimulation patients must not have:
- A neurological condition such as epilepsy, cerebrovascular disease, dementia, increased intracranial pressure or tumors in the central nervous system;
- A history of severe head trauma;
- Any metal implants in or around the head;
- A vagus nerve stimulator or implants controlled by physiologic signals, such as a pacemaker or an implantable cardioverter defibrillator.
For more information about transcranial magnetic stimulation therapy or to schedule a consult visit with a psychiatrist in PRI’s Walker Family Clinic, call (501) 526-8603.